Categories Biotech

50 posts

Auto Added by WPeMatico

Copy paste programmers

2021 should be a banner year for biotech startups that make smart choices early

Michael B. Gray Contributor Share on Twitter Michael B. Gray is partner and leader of the private equity, venture capital and growth companies practice, Neal Gerber Eisenberg. John Flavin Contributor Share on Twitter John Flavin is founder and CEO of Portal Innovations, LLC. Last year was a record 12 months […]

Copy paste programmers

Longevity startup Longevica plans to launch supplements based on long-term research

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. Longevica says it has attracted a total of $13 million from investors, including Alexander Chikunov, a longevity investor, who is also president of the company. Longevica says it […]

Copy paste programmers

Serimmune launches new immune response mapping service for COVID-19

Immune intelligence startup Serimmune hopes to better understand the relationship between antibody epitopes (the parts of antigen molecules that bind to antibodies) and the SARS-CoV-2 virus. The company’s proprietary technology, originally developed at UC Santa Barbara, provides a new and specific way of mapping the entire array of an individual’s […]

Copy paste programmers

Foresite Capital raises $969 million fund to invest in healthcare startups across all stages of growth

Health and life science specialist investment firm Foresite Capital has raised a new fund, its fifth to date, totally $969 million in commitments from LPs. This is the firm’s largest fund to date, and was oversubscribed relative to its original target according to fund CEO and founder Dr. Jim Tananbaum, […]

Copy paste programmers

Pfizer-BioNTech’s COVID-19 vaccine just got a lot easier to transport and distribute

The COVID-19 vaccine developed by Pfizer and BioNTech now has less stringent and extreme transportation requirements than when it debuted. Originally, the mRNA-based vaccine had to be maintained at ultra-low temperatures throughout the transportation chain in order to remain viable — between -76°F and -112°F. New stability data collected by […]

Copy paste programmers

Use today’s tech solutions to meet the climate crisis and do it profitably

Bertrand Piccard Contributor Share on Twitter Bertrand Piccard initiated the Solar Impulse Foundation after his history-making flight around the world in a solar-powered plane. Fueled only by the rays of the sun, his flight proved that existing methods and technologies can provide clean energy and solutions that protect the environment […]

Copy paste programmers

Mount Sinai study finds Apple Watch can predict COVID-19 diagnosis up to a week before testing

A new study from Mount Sinai researchers published in the peer-reviewed Journal of Medical Internet Research found that wearable hardware, and specifically the Apple Watch, can effectively predict a positive COVID-19 diagnosis up to a week before current PCR-based nasal swab tests. The investigation dubbed the ‘Warrior Watch Study,‘ used […]

Copy paste programmers

Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data

Another COVID-19 vaccine is almost ready to begin being distributed — a single-shot inoculation made by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary. The company just released an efficacy report based on data from its Phase 3 trial, which found that the new vaccine is 66% effective overall in preventing moderate […]

Copy paste programmers

Color raises $167 million funding at $1.5 billion valuation to expand ‘last mile’ of US health infrastructure

Healthcare startup Color has raised a sizable $167 million in Series D funding round, at a valuation of $1.5 billion post-money, the company announced today. This brings the total raised by Color to $278 million, with its latest large round intended to help it build on a record year of […]

Copy paste programmers

23andMe raises $82.5 million in new funding

DNA testing technology company 23andMe has raised just shy of $82.5 million in new funding, from an offering of $85 million in total equity shares, according to a new SEC filing. The funding, confirmed by the Wall Street Journal, comes from investors including Sequoia Capital and NewView Capital. It brings […]